drugset / Trial / NCT00774046

High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML

NCT00774046

Phase 2 Completed 32 enrolled University of Chicago
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the effectiveness of a particular combination of drugs used to treat cancer.

Timeline

Start
2002-12
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Cytarabine Small molecule 2000 mg/m2 Intravenous
Subject Etoposide Small molecule 30 mg/kg
Subject Mitoxantrone Small molecule 30 mg/m2